Clinical trial
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
NCT00349388 · Annette Langseder, Other · Terminated
Key facts
| NCT number | NCT00349388 |
|---|---|
| Title | Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients |
| Official title | A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis |
| Lead sponsor | Annette Langseder, Other |
| Collaborators | Procter and Gamble Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Asacol |
| Enrollment | 1 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Jul 7, 2006 |
| Last update posted | Jan 29, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: